Cargando…
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
The Hippo pathway regulates organ size, growth and comprises several tumor related factors, including the oncoprotein YAP1 and the tumor suppressor RASSF1A. RASSF1A is frequently epigenetically inactivated in cancer. In our study, we analyzed the effect of RASSF1A on the function of YAP1. Expression...
Autores principales: | Jiménez, Adriana P., Traum, Annalena, Boettger, Thomas, Hackstein, Holger, Richter, Antje M., Dammann, Reinhard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687617/ https://www.ncbi.nlm.nih.gov/pubmed/29179447 http://dx.doi.org/10.18632/oncotarget.18177 |
Ejemplares similares
-
The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012) -
Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer
por: Dammann, Reinhard H., et al.
Publicado: (2017) -
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010) -
RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice
por: Richter, Antje M., et al.
Publicado: (2020) -
Epigenetically inactivated RASSF1A as a tumor biomarker
por: Raos, Dora, et al.
Publicado: (2021)